Nasdaq

With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in ...

CARDIFF, UNITED KINGDOM / ACCESS Newswire / March 19, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the ...